Back to directory
Ten63 Therapeutics

Ten63 Therapeutics

biotechDurhamseries_b
ten63tx.com

AI platform for cancer drug discovery

Founded
2018
HQ
Durham
Sector
biotech
Stage
series_b
Total raised
$45M
Last round
growth
Team size
1-19
Affiliation
Duke

Founder profiles, enrichment notes, funding history, and investor connections are available to signed-in members.

Sign in to view full record